Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy
The latest episode of the Debunked podcast explored an ongoing debate questioning the role of…
Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy
The latest episode of the Debunked podcast explored an ongoing debate questioning the role of payers in healthcare transactions. It also highlighted turmoil at the CDC.. The post Debunked Episode 19: Turmoil at the CDC, Epic’s AI Strategy appeared first on MedCity News.
Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department
Early diagnostics for acute intoxication in the emergency department are about more than just identifying the cause of an overdose. They can enable timely intervention, reduce the risk of fatal outcomes, and open the door to substance use disorder treatment and recovery The post Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in…
Changing COVID-19 Booster Policies and Florida’s Decision to End Vaccine Mandates Create Confusion — The Monitor
This volume explores confusion around COVID-19 booster eligibility as federal recommendations shift and conflicts with guidance from physician organizations; Florida’s decision to end school vaccine mandates; and research demonstrating that artificial intelligence chatbots can provide generally sound advice, but struggle to make personalized recommendations.
Affirmative Action Critics Refuse To Back Down in Fight Over Medical Bias Training
Critics of affirmative action have launched a long-shot appeal aimed at stopping California from requiring training on unconscious bias in every continuing medical education class. A July ruling by a three-judge panel of the 9th U.S. Circuit Court of Appeals upheld California’s right to mandate that every course doctors take to remain licensed must address…
Climate Activists Cite Health Hazards in Bid To Stop Trump From ‘Unleashing’ Fossil Fuels
HELENA, Mont. — In 2023, a group of 16 young Montanans won a much-heralded climate change case that said the state had deprived them of a “clean and healthful environment,” a right enshrined in Montana’s constitution. Their victory in Held v. Montana, later upheld by the state Supreme Court, resounded across the country, showing that…
Watch: Patient Numbers at NIH Hospital Tumble After Trump Cuts
Government documents viewed by KFF Health News show a drop in patients receiving care this year at the National Institutes of Health’s renowned research hospital, a 200-bed facility at NIH headquarters in Maryland. We previously reported a decrease in the number of patients being treated at the NIH Clinical Center from February through April. Since then,…
Telehealth safe harbor: a call to action for health plans
By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful Bill was a significant milestone in virtual care. Though it specifically addresses pre-deductible telehealth services in high-deductible health plans, the legislation has far wider implications for both care delivery and insurance design, especially in the commercial insurance market. In fact…
Positioning & Distribution Will Determine the Winning Healthcare AI Startups, Investor Says
In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workflows are streamlined and value is delivered across stakeholders. This will differentiate winning AI startups from incumbents and copycat competitors, said Morgan Cheatham, head of healthcare and life sciences at Breyer Capital. The post…
A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds
Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs. The post A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds appeared first on MedCity News.
FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option
A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from its 2019 acquisition of Taris Biomedical. The post FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option appeared…
